查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1617082

到 2030 年過敏性結膜炎市場預測：按類型、年齡層、藥物類型、藥物類別、劑型、分銷管道、最終用戶和地區進行的全球分析

Allergic Conjunctivitis Market Forecasts to 2030 - Global Analysis By Type, Age Group, Drug Type, Drug Class, Formulation, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球過敏性結膜炎市場規模將達到 32 億美元，預計 2030 年將達到 46 億美元，預測期內複合年成長率為 6.3%。

過敏性結膜炎是一種眼睛炎症，由對花粉、塵蟎、寵物皮屑或黴菌等物質的過敏反應引起。它通常會影響雙眼，症狀包括發紅、發癢、水樣分泌物和腫脹。這種情況是由於接觸過敏原後結膜（覆蓋眼白的膜）中的組織胺被活化引起的。

根據 NLM 的一篇報導，過敏性眼科疾病影響著北美約 40% 的人口。

眼睛過敏增加

過敏性眼科疾病（尤其是結膜炎）的增加增加了對治療解決方案的需求。病例數的增加與污染、過敏原和氣候變遷等環境因素有關，促使醫療專業人員專注於有效的治療方法。隨著越來越多的人尋求緩解症狀，大眾對過敏性結膜炎的認知不斷提高也有助於市場擴張。

治療費用高

過敏性結膜炎的藥物治療、診斷測試和長期治療等治療費用高昂，是市場的主要限制因素。對許多患者來說，負擔得起的治療很困難，特別是在中低收入地區，限制了市場的成長潛力。此外，醫療保健差距和保險覆蓋範圍不足也加劇了經濟問題。

網路藥局成長

電子商務的興起，特別是在線藥房的擴張，正在為過敏性結膜炎市場創造巨大的成長機會。患者現在可以透過這些平台輕鬆獲得處方藥和非處方治療。便利性、有競爭力的價格和送貨上門的選擇可能有助於提高產品的可及性並推動市場成長。

與學名藥的競爭

學名藥供應量的增加對過敏性結膜炎市場上的品牌產品構成了威脅。學名藥以較低的價格提供相同的功效，越來越受歡迎，尤其是在價格敏感的市場。這種變化正在威脅創新藥物開發商的市場佔有率，迫使他們採取新的策略，例如付加產品差異化和改善患者治療結果。

COVID-19 的影響：

COVID-19 大流行擾亂了全球醫療保健系統，並影響了過敏性結膜炎的診斷和治療。社交距離措施、關門以及將醫療資源轉移到 COVID-19 上，加劇了眼睛過敏管理的挑戰。然而，對醫療保健的日益關注和數位醫療保健平台的更多使用減輕了其中一些影響，並促進了持續獲得治療。

預計季節性過敏性結膜炎在預測期內將是最大的部分

在預測期內，季節性過敏性結膜炎預計仍將是最大的市場區隔。此病在某些季節流行，特別是在花粉數量增加的春季和秋季。因此，更多的患者在這段時間尋求治療，增加了對抗組織胺和減充血劑等治療方案的需求，推動了該行業的成長。

預測期內，眼科診所產業預計複合年成長率最高

在估計和預測期內，預計眼科診所行業的年平均成長率最高。這些診所提供的專業服務以及先進的診斷技術和針對過敏性結膜炎的標靶治療越來越受歡迎。人們對眼睛健康的認知不斷提高，導致更多患者尋求專門治療，從而促進了該細分市場的成長。

比最大的地區

預計在預測期內，北美將主導過敏性結膜炎市場佔有率。該地區先進的醫療基礎設施、高度的認知度以及多種治療選擇的可用性是推動市場成長的關鍵因素。此外，北美過敏性疾病的日益普及也增加了對結膜炎治療的需求。

複合年成長率最高的地區：

預計亞太地區在預測期內過敏性結膜炎市場的複合年成長率最高。這一成長歸因於印度和中國等新興國家過敏性疾病盛行率的上升、都市化的提高以及醫療保健服務範圍的擴大。此外，不斷成長的中產階級人口和不斷變化的生活方式進一步推動了該地區對過敏治療的需求。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球過敏性結膜炎市場：按類型

  • 季節性過敏性結膜炎
  • 常年性過敏性結膜炎
  • 巨乳頭性結膜炎
  • 春卡他
  • 特應性角結膜炎

第6章全球過敏性結膜炎市場：依年齡層

  • 兒童（18歲以下）
  • 成人（18歲以上）

第7章全球過敏性結膜炎市場：依藥物類型

  • 處方藥
  • 非處方藥 (OTC)

第8章全球過敏性結膜炎市場：依藥物類別

  • 抗組織胺和肥大細胞穩定劑
  • 皮質類固醇
  • 免疫調節劑
  • NSAIDs
  • 人工淚液和潤滑劑

第9章全球過敏性結膜炎市場：按劑型

  • 眼藥水
  • 眼藥膏
  • 口腔醫學

第10章全球過敏性結膜炎市場：按分銷管道

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第11章全球過敏性結膜炎市場：依最終用戶分類

  • 眼科診所
  • 醫院
  • 門診手術中心

第12章全球過敏性結膜炎市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第13章 主要進展

  • 合約、夥伴關係、合作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第14章 公司概況

  • Alcon
  • Allergan
  • Bausch Health Companies Inc.
  • Novartis AG
  • Santen Pharmaceutical Co., Ltd.
  • Sun Pharma Advanced Research Company
  • Laboratoires Thea
  • Aciex Therapeutics
  • Sirion Therapeutics
  • Boehringer Ingelheim
  • Atopix Therapeutics
  • Laila Pharmaceuticals
  • Regeneron Pharmaceuticals, Inc.
  • Auven Therapeutics
  • Johnson & Johnson Vision
  • Sanofi
  • Zhaoke Ophthalmology Limited
  • Oyster Point Pharma
Product Code: SMRC27960

According to Stratistics MRC, the Global Allergic Conjunctivitis Market is accounted for $3.2 billion in 2024 and is expected to reach $4.6 billion by 2030 growing at a CAGR of 6.3% during the forecast period. Allergic conjunctivitis is an inflammation of the eyes resulting from an allergic reaction to substances like pollen, dust mites, pet dander, or mold. It usually affects both eyes and has symptoms like redness, itching, watery discharge, and swelling. The condition results from the activation of histamines in the conjunctiva, which is the membrane covering the white part of the eyes, upon exposure to allergens.

According to an article in NLM, in North America, approximately 40% of the population is affected by allergic eye disease.

Market Dynamics:

Driver:

Increasing prevalence of eye allergies

The growing number of allergic eye conditions, particularly conjunctivitis, is driving demand for treatment solutions. The rising cases are linked to environmental factors like pollution, allergens, and climate change, prompting healthcare professionals to focus on effective therapies. The increasing awareness of allergic conjunctivitis among the population is also contributing to the market's expansion as more individuals seek relief from symptoms.

Restraint:

High treatment costs

The high cost of treatments, including medications, diagnostic tests, and long-term management of allergic conjunctivitis, is a significant restraint in the market. Many patients find it challenging to access affordable care, especially in low- and middle-income regions, which limits the growth potential of the market. Additionally, healthcare disparities and inadequate insurance coverage also exacerbate the affordability challenge.

Opportunity:

Growth of online pharmacies

The rise of e-commerce, particularly the expansion of online pharmacies, presents significant growth opportunities for the allergic conjunctivitis market. Patients now have easier access to prescribed medications and over-the-counter treatments through these platforms. The convenience, competitive pricing, and doorstep delivery options contribute to increased product accessibility, which could fuel market growth.

Threat:

Competition from generic drugs

The growing availability of generic alternatives poses a threat to branded products in the allergic conjunctivitis market. Generic drugs, offering the same efficacy at lower prices, are gaining popularity, especially in price-sensitive markets. This shift threatens the market share of innovative drug developers, forcing them to adopt new strategies such as differentiating their products with added value or improving patient outcomes.

Covid-19 Impact:

The COVID-19 pandemic disrupted healthcare systems globally, impacting the diagnosis and treatment of allergic conjunctivitis. Social distancing measures, lockdowns, and the redirection of healthcare resources towards COVID-19 exacerbated the challenges in managing eye allergies. However, the increased focus on hygiene and the growing use of digital healthcare platforms helped mitigate some of these impacts, facilitating continued treatment access.

The seasonal allergic conjunctivitis segment is expected to be the largest during the forecast period

Over the estimation period, the seasonal allergic conjunctivitis segment is expected to remain the largest segment. This condition is more prevalent during specific seasons, particularly spring and autumn when pollen levels rise. As a result, a higher number of patients seek medical attention during these periods, driving demand for treatment options like antihistamines and decongestants, boosting the segment growth.

The ophthalmology clinics segment is expected to have the highest CAGR during the forecast period

Over the estimation period, the ophthalmology clinics segment is expected to experience the highest compound annual growth rate during the forecast period. The specialized services offered by these clinics, along with advanced diagnostic techniques and targeted therapies for allergic conjunctivitis, make them increasingly popular. As awareness of eye health increases, more patients are seeking specialized care, contributing to the growth of this segment.

Region with largest share:

North America is anticipated to dominate the allergic conjunctivitis market share during the forecast period. The region's advanced healthcare infrastructure, high awareness levels, and the availability of a wide range of treatment options are key factors driving market growth. Additionally, the increasing prevalence of allergic diseases in North America contributes to the demand for conjunctivitis treatments.

Region with highest CAGR:

The Asia Pacific region is projected to register the highest CAGR in the allergic conjunctivitis market during the forecast period. This growth is attributed to the rising incidence of allergic diseases, increasing urbanization, and the expansion of healthcare access in developing countries like India and China. Additionally, the growing middle-class population and changing lifestyle factors further fuel the demand for allergy treatments in this region.

Key players in the market

Some of the key players in Allergic Conjunctivitis Market include Alcon, Allergan, Bausch Health Companies Inc., Novartis AG, Santen Pharmaceutical Co., Ltd., Sun Pharma Advanced Research Company, Laboratoires Thea, Aciex Therapeutics, Sirion Therapeutics, Boehringer Ingelheim, Atopix Therapeutics, Laila Pharmaceuticals, Regeneron Pharmaceuticals, Inc., Auven Therapeutics, Johnson & Johnson Vision, Sanofi, Zhaoke Ophthalmology Limited, and Oyster Point Pharma.

Key Developments:

In March 2024, Santen Pharmaceutical Co., Ltd. (hereinafter Santen) has announced that it successfully obtained manufacturing and marketing approval, for a new long-acting, trans-eyelid formulation for treating allergic conjunctivitis, "Alesion(R) eyelid cream 0.5%" (generic name: epinastine hydrochloride, development code: STN1011402). Alesion(R) eyelid cream 0.5% is a cream-type formulation to be applied to the periocular area (upper and lower eyelids) once a day. It is the world's first cream-format treatment for allergic conjunctivitis.

In February 2021, Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced that Pataday(R) Once Daily Relief Extra Strength (olopatadine hydrochloride ophthalmic solution 0.7%) is now available in-store and online at U.S. retailers, following its 2020 approval by the Food and Drug Administration (FDA) for sale over-the-counter (OTC).

Types Covered:

  • Seasonal Allergic Conjunctivitis
  • Perennial Allergic Conjunctivitis
  • Giant Papillary Conjunctivitis
  • Vernal Keratoconjunctivitis
  • Atopic Keratoconjunctivitis

Age Groups Covered:

  • Pediatric (Below 18 years)
  • Adult (18 years and above)

Drug Types Covered:

  • Prescription Drugs
  • Over-the-Counter (OTC) Drugs

Drug Classes Covered:

  • Antihistamine & Mast Cell Stabilizers
  • Corticosteroids
  • Immunomodulators
  • NSAIDs
  • Artificial Tears & Lubricants

Formulations Covered:

  • Eye Drops
  • Eye Ointments
  • Oral Medications

Distribution Channels Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

End Users Covered:

  • Ophthalmology Clinics
  • Hospitals
  • Ambulatory Surgical Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Allergic Conjunctivitis Market, By Type

  • 5.1 Introduction
  • 5.2 Seasonal Allergic Conjunctivitis
  • 5.3 Perennial Allergic Conjunctivitis
  • 5.4 Giant Papillary Conjunctivitis
  • 5.5 Vernal Keratoconjunctivitis
  • 5.6 Atopic Keratoconjunctivitis

6 Global Allergic Conjunctivitis Market, By Age Group

  • 6.1 Introduction
  • 6.2 Pediatric (Below 18 years)
  • 6.3 Adult (18 years and above)

7 Global Allergic Conjunctivitis Market, By Drug Type

  • 7.1 Introduction
  • 7.2 Prescription Drugs
  • 7.3 Over-the-Counter (OTC) Drugs

8 Global Allergic Conjunctivitis Market, By Drug Class

  • 8.1 Introduction
  • 8.2 Antihistamine & Mast Cell Stabilizers
  • 8.3 Corticosteroids
  • 8.4 Immunomodulators
  • 8.5 NSAIDs
  • 8.6 Artificial Tears & Lubricants

9 Global Allergic Conjunctivitis Market, By Formulation

  • 9.1 Introduction
  • 9.2 Eye Drops
  • 9.3 Eye Ointments
  • 9.4 Oral Medications

10 Global Allergic Conjunctivitis Market, By Distribution Channel

  • 10.1 Introduction
  • 10.2 Hospital Pharmacies
  • 10.3 Retail Pharmacies
  • 10.4 Online Pharmacies

11 Global Allergic Conjunctivitis Market, By End User

  • 11.1 Introduction
  • 11.2 Ophthalmology Clinics
  • 11.3 Hospitals
  • 11.4 Ambulatory Surgical Centers

12 Global Allergic Conjunctivitis Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Alcon
  • 14.2 Allergan
  • 14.3 Bausch Health Companies Inc.
  • 14.4 Novartis AG
  • 14.5 Santen Pharmaceutical Co., Ltd.
  • 14.6 Sun Pharma Advanced Research Company
  • 14.7 Laboratoires Thea
  • 14.8 Aciex Therapeutics
  • 14.9 Sirion Therapeutics
  • 14.10 Boehringer Ingelheim
  • 14.11 Atopix Therapeutics
  • 14.12 Laila Pharmaceuticals
  • 14.13 Regeneron Pharmaceuticals, Inc.
  • 14.14 Auven Therapeutics
  • 14.15 Johnson & Johnson Vision
  • 14.16 Sanofi
  • 14.17 Zhaoke Ophthalmology Limited
  • 14.18 Oyster Point Pharma

List of Tables

  • Table 1 Global Allergic Conjunctivitis Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Allergic Conjunctivitis Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Allergic Conjunctivitis Market Outlook, By Seasonal Allergic Conjunctivitis (2022-2030) ($MN)
  • Table 4 Global Allergic Conjunctivitis Market Outlook, By Perennial Allergic Conjunctivitis (2022-2030) ($MN)
  • Table 5 Global Allergic Conjunctivitis Market Outlook, By Giant Papillary Conjunctivitis (2022-2030) ($MN)
  • Table 6 Global Allergic Conjunctivitis Market Outlook, By Vernal Keratoconjunctivitis (2022-2030) ($MN)
  • Table 7 Global Allergic Conjunctivitis Market Outlook, By Atopic Keratoconjunctivitis (2022-2030) ($MN)
  • Table 8 Global Allergic Conjunctivitis Market Outlook, By Age Group (2022-2030) ($MN)
  • Table 9 Global Allergic Conjunctivitis Market Outlook, By Pediatric (Below 18 years) (2022-2030) ($MN)
  • Table 10 Global Allergic Conjunctivitis Market Outlook, By Adult (18 years and above) (2022-2030) ($MN)
  • Table 11 Global Allergic Conjunctivitis Market Outlook, By Drug Type (2022-2030) ($MN)
  • Table 12 Global Allergic Conjunctivitis Market Outlook, By Prescription Drugs (2022-2030) ($MN)
  • Table 13 Global Allergic Conjunctivitis Market Outlook, By Over-the-Counter (OTC) Drugs (2022-2030) ($MN)
  • Table 14 Global Allergic Conjunctivitis Market Outlook, By Drug Class (2022-2030) ($MN)
  • Table 15 Global Allergic Conjunctivitis Market Outlook, By Antihistamine & Mast Cell Stabilizers (2022-2030) ($MN)
  • Table 16 Global Allergic Conjunctivitis Market Outlook, By Corticosteroids (2022-2030) ($MN)
  • Table 17 Global Allergic Conjunctivitis Market Outlook, By Immunomodulators (2022-2030) ($MN)
  • Table 18 Global Allergic Conjunctivitis Market Outlook, By NSAIDs (2022-2030) ($MN)
  • Table 19 Global Allergic Conjunctivitis Market Outlook, By Artificial Tears & Lubricants (2022-2030) ($MN)
  • Table 20 Global Allergic Conjunctivitis Market Outlook, By Formulation (2022-2030) ($MN)
  • Table 21 Global Allergic Conjunctivitis Market Outlook, By Eye Drops (2022-2030) ($MN)
  • Table 22 Global Allergic Conjunctivitis Market Outlook, By Eye Ointments (2022-2030) ($MN)
  • Table 23 Global Allergic Conjunctivitis Market Outlook, By Oral Medications (2022-2030) ($MN)
  • Table 24 Global Allergic Conjunctivitis Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 25 Global Allergic Conjunctivitis Market Outlook, By Hospital Pharmacies (2022-2030) ($MN)
  • Table 26 Global Allergic Conjunctivitis Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 27 Global Allergic Conjunctivitis Market Outlook, By Online Pharmacies (2022-2030) ($MN)
  • Table 28 Global Allergic Conjunctivitis Market Outlook, By End User (2022-2030) ($MN)
  • Table 29 Global Allergic Conjunctivitis Market Outlook, By Ophthalmology Clinics (2022-2030) ($MN)
  • Table 30 Global Allergic Conjunctivitis Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 31 Global Allergic Conjunctivitis Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.